CID 169292289

Darlifarnib

Structural Information

Molecular Formula
C29H20N6O
SMILES
CN1C=NC=C1[C@]2(C3=CC(=C(C=C3)C#N)COC4=CC=CC(=C4)C5=C6C=C2C=CC6=NC(=C5)C#N)N
InChI
InChI=1S/C29H20N6O/c1-35-17-33-15-28(35)29(32)21-6-5-19(13-30)20(9-21)16-36-24-4-2-3-18(10-24)25-12-23(14-31)34-27-8-7-22(29)11-26(25)27/h2-12,15,17H,16,32H2,1H3/t29-/m1/s1
InChIKey
GWKGWWBQKOIPNP-GDLZYMKVSA-N
Compound name
(14S)-14-amino-14-(3-methylimidazol-4-yl)-7-oxa-19-azapentacyclo[13.6.2.12,6.19,13.018,22]pentacosa-1(22),2(25),3,5,9,11,13(24),15(23),16,18,20-undecaene-10,20-dicarbonitrile
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

3
Patents

468.16986 Da
Monoisotopic Mass

3.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 469.17714 212.3
[M+Na]+ 491.15908 225.7
[M-H]- 467.16258 210.0
[M+NH4]+ 486.20368 217.1
[M+K]+ 507.13302 209.5
[M+H-H2O]+ 451.16712 195.1
[M+HCOO]- 513.16806 215.7
[M+CH3COO]- 527.18371 214.1
[M+Na-2H]- 489.14453 212.8
[M]+ 468.16931 205.0
[M]- 468.17041 205.0
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe